Core Viewpoint - The company, Global Medical (02666.HK), has received approval from the China Securities Regulatory Commission to publicly issue a maximum of RMB 2 billion in domestic renewable corporate bonds aimed at qualified investors, with a remaining quota of RMB 650 million as of the announcement date [1] Group 1 - The bond issuance will be conducted in tranches, with the total principal amount for this issuance not exceeding RMB 300 million [1] - The basic term of the corporate bond is set at 1 year, with the issuer having the option to extend the term by one repricing cycle or fully redeem the bond at the end of the basic term and each repricing cycle [1] - The bond includes options for the issuer to renew, defer interest payments, and redeem, with a fixed interest rate for the first cycle determined through a book-building process [1] Group 2 - The interest rate for subsequent cycles will be adjusted to the current benchmark rate plus the initial spread plus an additional 300 basis points [1] - The net proceeds from this bond issuance will be used by the issuer to supplement operational funds [1]
环球医疗(02666.HK)附属中国环球租赁拟发行不超过3亿元公司债